Ruslan Rafikov

Dr. Ruslan Rafikov

University of Arizona
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2002 in Cell
Verified
Journal Article
Closed access
AMalexander mironov
alexander mironov
IGIvan Gusarov
Ivan Gusarov
RRRuslan Rafikov
Ruslan Rafikov
LLLubov Errais Lopez
Lubov Errais Lopez
KSKonstantin Shatalin
Konstantin Shatalin
ENEvgeny Nudler
Evgeny Nudler

1 January 2005 in Cell
Verified
Journal Article
Closed access
GBGil Bar-Nahum
Gil Bar-Nahum
VEVitaly Epshtein
Vitaly Epshtein
ARAndrei E. Ruckenstein
Andrei E. Ruckenstein
RRRuslan Rafikov
Ruslan Rafikov
AMArkady Mustaev
Arkady Mustaev
ENEvgeny Nudler
Evgeny Nudler

3 June 2011 in Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
RRRuslan Rafikov
Ruslan Rafikov
FFFabio V Fonseca
Fabio V Fonseca
SKSanjiv Kumar
Sanjiv Kumar
DPDaniel Pardo
Daniel Pardo
CDCharles Darragh
Charles Darragh
SBStephen Black
Stephen Black
Rather than being a constitutive enzyme as was first suggested, endothelial nitric oxide synthase (eNOS) is dynamically regulated at the transcriptional, posttranscriptional, and posttranslational levels. This review will focus on how changes in eNOS function are conferred by various posttranslational modifications. The latest knowledge regarding eNOS targeting to the plasma membrane will be discussed as the role of protein phosphorylation as a modulator of catalytic activity. Furthermore, new data are presented that provide novel insights into how disruption of the eNOS dimer prevents eNOS uncoupling and the production of superoxide under conditions of elevated oxidative stress and identifies a novel regulatory region we have termed the ‘flexible arm’.

1 August 2014 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
SBScott A. Barman
Scott A. Barman
FCFeng Chen
Feng Chen
YSYunchao Su
Yunchao Su
CDChristiana Dimitropoulou
Christiana Dimitropoulou
YWYusi Wang
Yusi Wang
DFDavid J.R. Fulton
David J.R. Fulton
Objective—: Pulmonary hypertension (PH) is a progressive disease arising from remodeling and narrowing of pulmonary arteries (PAs) resulting in high pulmonary blood pressure and ultimately right ventricular failure. Elevated production of reactive oxygen species by NADPH oxidase 4 (Nox4) is associated with increased pressure in PH. However, the cellular location of Nox4 and its contribution to aberrant vascular remodeling in PH remains poorly understood. Therefore, we sought to identify the vascular cells expressing Nox4 in PAs and determine the functional relevance of Nox4 in PH. Approach and Results—: Elevated expression of Nox4 was detected in hypertensive PAs from 3 rat PH models and human PH using qualititative real-time reverse transcription polymerase chain reaction, Western blot, and immunofluorescence. In the vascular wall, Nox4 was detected in both endothelium and adventitia, and perivascular staining was prominently increased in hypertensive lung sections, colocalizing with cells expressing fibroblast and monocyte markers and matching the adventitial location of reactive oxygen species production. Small-molecule inhibitors of Nox4 reduced adventitial reactive oxygen species generation and vascular remodeling as well as ameliorating right ventricular hypertrophy and noninvasive indices of PA stiffness in monocrotaline-treated rats as determined by morphometric analysis and high-resolution digital ultrasound. Nox4 inhibitors improved PH in both prevention and reversal protocols and reduced the expression of fibroblast markers in isolated PAs. In fibroblasts, Nox4 overexpression stimulated migration and proliferation and was necessary for matrix gene expression. Conclusion—: These findings indicate that Nox4 is prominently expressed in the adventitia and contributes to altered fibroblast behavior, hypertensive vascular remodeling, and development of PH.

28 November 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ANAndrey Nedospasov
Andrey Nedospasov
RRRuslan Rafikov
Ruslan Rafikov
NBNatalya Beda
Natalya Beda
ENEvgeny Nudler
Evgeny Nudler
Nitros(yl)ation is a widespread protein modification that occurs during many physiological and pathological processes. It can alter both the activity and function of a protein. Nitric oxide ( ⋅ NO) has been implicated in this process, but its mechanism remained uncertain. ⋅ NO is unable to react with nucleophiles under oxygen-free conditions, suggesting that its higher oxides, such as N 2 O 3 , were actually nitrosylating agents. However, low concentrations and short lifespans of these species in vivo raise the question of how they could efficiently locate target proteins. Here we demonstrate that at physiological concentrations of ⋅ NO, N 2 O 3 forms inside protein-hydrophobic cores and causes nitrosylation within the protein interior. This mechanism of protein modification has not been characterized, because all previously described mechanisms (e.g., phosphorylation, acetylation, ADP-ribosylation, etc.) occur via attack on a protein by an external modification agent. Oxidation of ⋅ NO to N 2 O 3 is facilitated by micellar catalysis, which is mediated by the hydrophobic phase of proteins. Thus, a target protein seems to be a catalyst of its own nitrosylation. One of the applications of this finding, as we report here, is the design of specific hydrophobic compounds whose cooperation with ⋅ NO and O 2 allows the rapid inactivation of target enzymes to occur.

30 April 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
OROlga Rafikova
Olga Rafikova
RRRuslan Rafikov
Ruslan Rafikov
ENEvgeny Nudler
Evgeny Nudler
Nitric oxide (NO ⋅ ) is a short-lived physiological messenger. Its various biological activities can be preserved in a more stable form of S -nitrosothiols (RS-NO). Here we demonstrate that at physiological NO ⋅ concentrations, plasma albumin becomes saturated with NO ⋅ and accelerates formation of low-molecular-weight (LMW) RS-NO in vitro and in vivo . The mechanism involves micellar catalysis of NO ⋅ oxidation in the albumin hydrophobic core and specific transfer of NO + to LMW thiols. Albumin-mediated S -nitrosylation and its vasodilatory effect directly depend on the concentration of circulating LMW thiols. Results suggest that the hydrophobic phase formed by albumin serves as a major reservoir of NO ⋅ and its reactive oxides and controls the dynamics of NO ⋅ -dependant processes in the vasculature.